Virus-based therapy takes on stubborn cancers in early trial
Disease control
Not yet recruiting
This early-stage study tests a new drug called OTS-412, made from a modified virus, alone or with other medicines in 24 adults whose solid tumors have stopped responding to standard treatments. The main goal is to check safety and side effects, while also looking at whether the t…
Phase: PHASE1 • Sponsor: Bionoxx Inc. • Aim: Disease control
Last updated May 17, 2026 07:38 UTC